Be Part of the CURE banner_DRI lobby

George Burke, III, M.D.

"While a kidney-pancreas transplant offers benefits to individual recipients with type 1 diabetes, Dr. Pugliese and I hope and believe that our study on the mechanisms of recurrence of autoimmunity in the pancreas transplant may lead to new therapies for both transplant recipients and young patients newly diagnosed with type 1 diabetes."

George W. Burke III, M.D., F.A.C.S., is a Professor of Surgery at the University of Miami Miller School of Medicine. He also serves as Director of the Kidney, Kidney/Pancreas Transplant Program, and Co-Director of the Division of Transplantation, where he works in both a clinical and research capacity.

Dr. Burke has a unique interest in the clinical utility of basic science research, and specifically, the role of cytokines in transplantation immunobiology.

He is currently studying the relevance of serum cytokines in transplant recipients who are clinically tolerant; and novel approaches to therapy to prevent recurrence of proteinuria in children who receive kidney transplants for focal segmental glomerulosclerosis.

Dr. Burke is the author and/or co-author of over 380 peer-reviewed articles in the field of solid organ transplantation and research in pancreas, liver and kidney transplantation. He has presented numerous papers at national and international scientific congresses.

He is the Principal Investigator or Co-Investigator of several funded research programs. For the past two years in collaboration with Dr. Alberto Pugliese of the DRI, Dr. Burke has been studying the recurrence of type 1 diabetes after kidney/pancreas transplantation that occurs in a small number of kidney/pancreas transplant recipients.

The potential for this work was recently recognized and funded by the NIH.

Keep up with our progress toward a cure & more

Be a DRI Insider - Get News!